| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.037 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |